Haque W, et al. - An inspection was carried out of the practice patterns, outcomes, and predictors of survival for elderly patients with glioblastoma (GBM) receiving definitive chemoradiotherapy (CRT) with either hypofractionated radiotherapy (hCRT) or conventionally fractionated radiotherapy. Data illustrated the increasing use of hCRT over time. It was determined that the delivery of hCRT independently predicted a poorer overall survival (OS).